Semaglutide GLP-1 may not be appropriate for everyone, especially those with a history of severe gastrointestinal problems, active pancreatitis, certain thyroid cancers, multiple endocrine neoplasia syndrome type 2, severe eating disorders, or a history of medullary thyroid carcinoma in ones family or personal
Inhibition of the MYC-regulated glutaminase metabolic axis Is an effective synthetic lethal approach for treating chemoresistant ovarian cancers
What works for one person won't necessarily work for another, and finding your right dose takes some trial and error
Effectiveness: what the evidence shows Clinical studies and real-world analyses show both drugs produce meaningful weight loss when used with lifestyle changes
Label your vials
In 2026, a more intelligent, science-backed approach is changing the conversation, and it starts with understanding your body's own chemistry